firmagon
ferring pharmaceuticals a/s - degarelix - prostatas audzēji - endokrīnā terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
karvidil 12,5 mg tabletes
grindeks, as, latvia - karvedilols - tablete - 12,5 mg
karvidil 25 mg tabletes
grindeks, as, latvia - karvedilols - tablete - 25 mg
karvidil 6,25 mg tabletes
grindeks, as, latvia - karvedilols - tablete - 6,25 mg
escitalopram grindeks 5 mg apvalkotās tabletes
grindeks, as, latvia - escitaloprāms - apvalkotā tablete - 5 mg
escitalopram grindeks 10 mg apvalkotās tabletes
grindeks, as, latvia - escitaloprāms - apvalkotā tablete - 10 mg
escitalopram grindeks 20 mg apvalkotās tabletes
grindeks, as, latvia - escitaloprāms - apvalkotā tablete - 20 mg
memantine grindeks 10 mg apvalkotās tabletes
grindeks, as, latvia - memantīna hidrohlorīds - apvalkotā tablete - 10 mg
sitagliptin/metformin grindeks 50 mg/850 mg apvalkotās tabletes
grindeks, as, latvia - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg
sitagliptin/metformin grindeks 50 mg/1000 mg apvalkotās tabletes
grindeks, as, latvia - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg